7-Deaza-6-hydroxypurine

CAS : 3680-71-5

Ref. 3D-FD09328

Informations sur le produit

• Nom: 7-Deaza-6-hydroxypurine
• Synonymes: 7-Deazahyoxanthine4H-Pyrrolo[2,3-d]pyrimidin-4-one, 1,7-Dihydropyrrolo[2,3-d]pyrimidin-4-one, 1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one, 1H,4H,7H-pyrrolo[2,3-d]pyrimidin-4-one, 1H-Pyrrolo[2,3-d]pyrimidin-4-ol, 3,7-Dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one, 3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one, 4-Hydro-7H-pyrrolo[2,3-d]pyrimidine, 4-Hydroxypyrrolo[2,3-D]Pyrimidine, 4H-Pyrrolo[2,3-d]pyrimidin-4-one, 1,7-dihydro-, 4H-Pyrrolo[2,3-d]pyrimidin-4-one, 3,7-dihydro-, 7-Deazahypoxanthine, 7H-Pyrrolo[2,3-d]pyrimidin-4-ol, NSC 124164, NSC 59251

Description

7-Deaza-6-hydroxypurine is a skeleton of nucleosides that inhibits enzymes. It has been shown to inhibit the activity of hydrochloric acid, a tumor metastasis promoter. The constant for this drug was determined using molecular modeling and inhibition constants. 7-Deaza-6-hydroxypurine has anticancer activity and can be used for the treatment of cancer. This drug is used as a noncompetitive inhibitor in which it binds to two different sites on the enzyme. It has also been shown to bind to subunits, which are parts of a protein that make up its structure, in biological studies.br>
7-Deaza-6-hydroxypurine is an inhibitor that binds to two different sites on an enzyme. It has been shown to have anticancer activity and can be used for the treatment of cancer. This drug is used as a noncompetitive inhibitor in which it binds to two different sites on the enzyme. It

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 135.12 g/mol
• Formule: C₆H₅N₃O
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder